Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SMBS
Schwab Mortgage-Backed Securities ETF
SMBS
|
+$5.08B |
| 2 |
Schwab Municipal Bond ETF
SCMB
|
+$1.29B |
| 3 |
Schwab US Large-Cap Growth ETF
SCHG
|
+$752M |
| 4 |
Microsoft
MSFT
|
+$699M |
| 5 |
NVIDIA
NVDA
|
+$578M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Mortgage-Backed Securities ETF
VMBS
|
+$4.9B |
| 2 |
Invesco FTSE RAFI US 1000 ETF
PRF
|
+$986M |
| 3 |
iShares National Muni Bond ETF
MUB
|
+$951M |
| 4 |
Invesco FTSE RAFI US 1500 Small-Mid ETF
PRFZ
|
+$794M |
| 5 |
Schwab Fundamental International Small Company Index ETF
FNDC
|
+$647M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.55% |
| 2 | Financials | 11.83% |
| 3 | Healthcare | 9.33% |
| 4 | Consumer Discretionary | 9.25% |
| 5 | Industrials | 8.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3351
Alto Neuroscience
ANRO
$1.09B
| $254K | ﹤0.01% |
115,263
-35,158
| -23% | -$83.7K |
|
3352
State Street SPDR Portfolio Aggregate Bond ETF
SPAB
$9.92B
| $252K | ﹤0.01% |
+9,832
| New | +$249K |
|
|
PAMT
3353
PAMT Corp
PAMT
$284M
| $245K | ﹤0.01% |
19,045
+36
| +0.2% | +$484 |
|
3354
PrimeEnergy Resources
PNRG
$321M
| $240K | ﹤0.01% |
1,638
-414
| -20% | -$71.8K |
|
|
ILLR
3355
Triller Group Inc
ILLR
$20M
| $239K | ﹤0.01% |
+25,639
| New | +$226K |
|
|
NOTE
3356
DELISTED
FiscalNote
NOTE
| $236K | ﹤0.01% |
36,651
-19,187
| -34% | -$144K |
|
|
AFCG
3357
AFC Gamma
AFCG
$63.2M
| $233K | ﹤0.01% |
52,096
-1,858
| -3% | -$9.57K |
|
|
MAPS
3358
DELISTED
WM TECHNOLOGY INC A
MAPS
| $233K | ﹤0.01% |
259,858
| – | – |
|
3359
Gaia
GAIA
$32.9M
| $232K | ﹤0.01% |
52,810
-1,953
| -4% | -$8.9K |
|
3360
Vanguard Russell 1000 ETF
VONE
$8.68B
| $231K | ﹤0.01% |
+823
| New | +$214K |
|
3361
Myomo
MYO
$56.2M
| $223K | ﹤0.01% |
103,061
+81,566
| +379% | +$296K |
|
3362
Korro Bio
KRRO
$201M
| $222K | ﹤0.01% |
17,776
-512
| -3% | -$7.37K |
|
3363
Crexendo
CXDO
$213M
| $220K | ﹤0.01% |
+36,277
| New | +$189K |
|
|
MPX
3364
DELISTED
Marine Products Corp
MPX
| $219K | ﹤0.01% |
25,735
-53
| -0.2% | -$443 |
|
3365
Journey Medical
DERM
$178M
| $219K | ﹤0.01% |
+30,451
| New | +$210K |
|
|
SNCR
3366
DELISTED
Synchronoss Technologies
SNCR
| $216K | ﹤0.01% |
+31,570
| New | +$262K |
|
3367
Biomea Fusion
BMEA
$94.2M
| $210K | ﹤0.01% |
116,549
-64,831
| -36% | -$125K |
|
|
SLSN
3368
Solesence Inc
SLSN
$71.3M
| $207K | ﹤0.01% |
+47,387
| New | +$166K |
|
|
AVR
3369
Anteris Technologies
AVR
$896M
| $204K | ﹤0.01% |
53,872
+18,124
| +51% | +$73.7K |
|
3370
Transcontinental Realty Investors
TCI
$321M
| $204K | ﹤0.01% |
+4,778
| New | +$162K |
|
|
TWFG
3371
TWFG Inc
TWFG
$355M
| $203K | ﹤0.01% |
+5,800
| New | +$193K |
|
3372
Lucid Diagnostics
LUCD
$188M
| $201K | ﹤0.01% |
+174,868
| New | +$226K |
|
3373
CytomX Therapeutics
CTMX
$750M
| $201K | ﹤0.01% |
88,570
+63,693
| +256% | +$103K |
|
|
FLYY
3374
DELISTED
Spirit Aviation Holdings, Inc.
FLYY
| $199K | ﹤0.01% |
+39,876
| New | +$238K |
|
3375
NLI Holdings
NL
$312M
| $198K | ﹤0.01% |
30,935
+5,220
| +20% | +$39.3K |
|
Similar funds
Charles Schwab's Q2 2025 Portfolio in Review
As of Q2 2025, Charles Schwab held 3,631 positions worth $578B, up 8.5% from $533B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Charles Schwab's Q2 2025 filing shows 158 new, 2,252 increased, 1,020 reduced and 137 closed positions. Its largest new stake was Schwab Mortgage-Backed Securities ETF: 202,020,489 shares worth $5.15B. The largest sale was Vanguard Mortgage-Backed Securities ETF, an estimated $4.9B.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 21% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q2 2025 buy was Schwab Mortgage-Backed Securities ETF: 202,020,489 shares worth $5.15B.
- Charles Schwab added most to Schwab Municipal Bond ETF in Q2 2025, an estimated $1.29B increase.
- Charles Schwab's biggest Q2 2025 reduction was Vanguard Mortgage-Backed Securities ETF, cutting an estimated $4.9B.
- Charles Schwab fully exited Invesco FTSE RAFI US 1000 ETF in Q2 2025, selling an estimated $986M.
- Charles Schwab's ten largest holdings make up 23% of its $578B portfolio in Q2 2025.
- Charles Schwab opened 158 new positions and closed 137 in Q2 2025.
- Charles Schwab's portfolio value rose 8.5% quarter-over-quarter to $578B.
Based on Charles Schwab's 13F filing for Q2 2025, filed 12 Aug 2025.